Complex involvement of nitric oxide and cGMP at N-methyl-d-aspartic acid receptors regulating γ-[3H]aminobutyric acid release from striatal slices☆
References (26)
- et al.
Possible involvement of nitric oxide in long term potentiation
Eur. J. Pharmacol.
(1991) - et al.
Nitric oxide synthase regulatory sites. Phosphorylation by cyclic AMP dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase; identification of flavin and calmodulin binding sites
J. Biol. Chem.
(1992) - et al.
NMDA-induced release of nitric oxide potentiates aspartate outflow from cereberal slices
Neurosci. Lett.
(1992) Glutamate, nitric oxide and cell-cell signalling in the nervous system
Trends Neurosci.
(1991)- et al.
NMDA receptor channels: subunit-specific potentiation by reducing agents
Neuron
(1994) - et al.
Carrier-mediated release of neuro-transmitters
Trends Neurosci.
(1993) - et al.
Nitric oxide induces neurotransmitter release from hippocampal slices
Eur. J. Pharmacol.
(1992) - et al.
N-Methyl-d-aspartate-induced nitric oxide release- an in vivo microdialysis study
Neuroscience
(1993) - et al.
Nitric oxide-induced blockade of NMDA receptors
Neuron
(1992) - et al.
Excitatory amino acid action on the release of brain neurotransmitters and neuromodulators
Prog. Neurobiol.
(1993)
Endogenous nitric oxide inhibits NMDA- and kainate-responses by a negative feed-back system in rat hippocampal neurones
Brain Res.
NMDA receptor activation in rat hippocampus induces cyclic GMP formation through the L-arginine/nitric oxide pathway
Neurosci. Lett.
NMDA and carbachol but not AMPA affect differently the release of [3H]GABA in striosome-and matrix-enriched areas of the rat striatum
Brain Res.
Cited by (22)
Nitric oxide in the nervous system. Biochemical, developmental, and neurobiological aspects
2014, Vitamins and HormonesCitation Excerpt :GABA release, mediated by NO, is cGMP-dependent in several hypothalamic nuclei (Yang, Chen, Li, & Pan, 2007) and in some instances PKGs may be involved as well (Li, Chen, Finnegan, & Pan, 2004). Many studies have demonstrated the involvement of NO in NMDA-stimulated GABA release (Hanania & Johnson, 1998; Ientile et al., 1997; Kano et al., 1998; Kendrick et al., 1996; Møller, Jones, & Beart, 1995) probably because NMDA can stimulate NO production by an NMDA-induced calcium influx. In the majority of these studies, NO mediates the increase in GABA release induced by NMDA.
Effect of nitric oxide synthase inhibitors on benzodiazepine withdrawal in mice and rats
2011, Pharmacological ReportsCitation Excerpt :Some authors have also demonstrated an inhibitory action of NO synthase inhibitors on precipitated nicotine withdrawal syndrome manifested by weight loss, decreases in motor activity, diarrhea and irritability in rats [19, 39]. Although there is evidence for interactions between the NO and benzodiazepines/GABAA systems in the central nervous system [13, 30, 56], studies that have evaluated the role of NO in benzodiazepine dependence are limited. Thus, the current studies were undertaken to investigate the effect of the NO synthase inhibitors L-NAME and L-NOARG on the expression of benzodiazepines withdrawal signs in mice and rats.
The interaction of sildenafil with the anticonvulsant effect of diazepam
2009, European Journal of PharmacologyRegulation of neurotransmitter release by endogenous nitric oxide in striatal slices
1998, European Journal of Pharmacology
- ☆
Supported by the National Health and Medical Research Council (Australia) of which P.M.B. is a Principal Research Fellow. M.M. acknowledges support from the Royal Danish School of Pharmacy.
- 1
Present address: Royal Danish School of Pharmacy, 2 Universitetsparken, DK-2100 Copenhagen, Denmark.